Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
41.83
+0.54 (1.31%)
At close: Jun 26, 2026, 4:00 PM EDT
41.96
+0.13 (0.31%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Indivior Pharmaceuticals Employees
As of December 31, 2025, Indivior Pharmaceuticals had 838 total employees, including 827 full-time and 11 part-time employees. The number of employees decreased by 213 or -20.27% compared to the previous year.
Employees
838
Change (1Y)
-213
Growth (1Y)
-20.27%
Revenue / Employee
$1,539,379
Profits / Employee
$300,716
Market Cap
5.10B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 890 |
| Supernus Pharmaceuticals | 778 |
| BioCryst Pharmaceuticals | 435 |
INDV News
- 8 days ago - Indivior initiated with an Overweight at Barclays - TheFly
- 5 weeks ago - Indivior reports real-world data for Sublocade in opioid use disorder - TheFly
- 5 weeks ago - New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization - GlobeNewsWire
- 6 weeks ago - Indivior to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Indivior announces $175M accelerated share repurchase program - TheFly
- 7 weeks ago - Indivior Announces $175 Million Accelerated Share Repurchase - GlobeNewsWire
- 2 months ago - Indivior reports Q1 EPS 96c, consensus 66c - TheFly
- 2 months ago - Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance - GlobeNewsWire